Orange Book product · Generic (ANDA)
LINCOMYCIN HYDROCHLORIDE
LINCOMYCIN HYDROCHLORIDE
At a glance
Mar 12, 2021
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 12, 2021
5 yr 4 mo ago
Today
Pharmaceutical detail
Active ingredient
LINCOMYCIN HYDROCHLORIDE
Strength
EQ 300MG BASE/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 212770
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of LINCOMYCIN HYDROCHLORIDE
- —LINCOCINBrand (NDA)
NDA 050316 · PHARMACIA AND UPJOHN
- —LINCOCINBrand (NDA)
NDA 050317 · PFIZER
- 2022LINCOMYCIN HYDROCHLORIDEGeneric (ANDA)
ANDA 216662 · SLATE RUN PHARMA
- 2022LINCOMYCIN HYDROCHLORIDEGeneric (ANDA)
ANDA 215657 · GLAND
- 2021LINCOMYCIN HYDROCHLORIDEGeneric (ANDA)
ANDA 215082 · MICRO LABS
- 2015LINCOMYCIN HYDROCHLORIDEGeneric (ANDA)
ANDA 201746 · XGEN PHARMS
- 1991LINCOMYCIN HYDROCHLORIDEGeneric (ANDA)
ANDA 063180 · SLAYBACK
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
